美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AgomAb Therapeutics

14.08

+1.269.83%

成交量：18.89萬

成交額：258.73萬

市值：6.93億

市盈率：-9.00

高：14.25

開：13.40

低：13.16

收：12.82

52周最高：17.82

52周最低：8.75

股本：4,924.80萬

流通股本：1,383.60萬

量比：3.36

換手率：1.37%

股息：- -

股息率：- -

每股收益(TTM):-1.5649

每股收益(LYR):-168.1598

淨資產收益率：-39.22%

總資產收益率：-20.58%

市淨率：6.43

市盈率(LYR):-0.08

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Agomab公布Ontunisertib治療纖維狹窄型克羅恩病的新時代2B期研究設計方案

Agomab獲美國專利授權肺靶向吸入式ALK5小分子抑制劑AGMB-447進入特發性肺纖維化治療研發階段

Leerink Partners首次覆蓋AgomAb Therapeutics，給予「跑贏大盤」評級，目標價36美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/AGMB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AGMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","market":"US","secType":"STK","nameCN":"AgomAb Therapeutics","latestPrice":14.08,"timestamp":1787682782134,"preClose":12.82,"halted":0,"volume":188893,"delay":0,"changeRate":0.09828393135725427,"floatShares":13836000,"shares":49248000,"eps":-1.5648936,"marketStatus":"交易中","change":1.26,"latestTime":"08-25 14:33:38 EDT","open":13.4,"high":14.25,"low":13.16,"amount":2587302.743991,"amplitude":0.085023,"askPrice":14.29,"askSize":100,"bidPrice":13.99,"bidSize":35,"shortable":3,"etf":0,"ttmEps":-1.5648936,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":12.82,"preHourTrading":{"tag":"盘前","latestPrice":13.3,"preClose":12.82,"latestTime":"08:41 EDT","volume":47,"amount":622.850016,"timestamp":1787661663477,"change":0.48,"changeRate":0.037441,"amplitude":0.0117},"postHourTrading":{"tag":"盘后","latestPrice":12.82,"preClose":12.82,"latestTime":"19:30 EDT","volume":8,"amount":102.56,"timestamp":1787614207230,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.361005},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","floatShares":13836000,"roa":"-20.58%","roe":"-39.22%","lyrEps":-168.159829,"volumeRatio":3.361005,"shares":49248000,"dividePrice":0,"high":14.25,"amplitude":0.085023,"preClose":12.82,"low":13.16,"week52Low":8.75,"pbRate":"6.43","week52High":17.82,"institutionHeld":0,"latestPrice":14.08,"committee":-0.481481,"eps":-1.5648936,"divideRate":0,"volume":188893,"delay":0,"ttmEps":-1.5648936,"open":13.4,"prevYearClose":16,"prevWeekClose":13.25,"prevMonthClose":12.87,"prevQuarterClose":12.98,"fiveDayClose":13.73,"twentyDayClose":12.54,"sixtyDayClose":11.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGMB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1787371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGMB","date":"2026-08-24","current":-8.997417,"percent":0.651852,"low":-14.725744,"twenty":-12.400375,"median":-8.978348,"eighty":-7.793482,"high":-6.52172,"avg":-9.67543,"sd":2.281087,"marketCap":652535668},"quantilePoints":[{"date":"2026-02-06","current":-14.293959,"twenty":-14.293959,"median":-14.293959,"eighty":-14.293959,"marketCap":779788464},{"date":"2026-02-13","current":-13.901135,"twenty":-14.202947,"median":-13.85921,"eighty":-13.805127,"marketCap":763217959},{"date":"2026-02-20","current":-13.975141,"twenty":-14.020702,"median":-13.811207,"eighty":-13.436782,"marketCap":760781120},{"date":"2026-02-27","current":-14.297833,"twenty":-14.274685,"median":-13.837477,"eighty":-13.631029,"marketCap":780275831},{"date":"2026-03-06","current":-12.944797,"twenty":-14.315694,"median":-13.869306,"eighty":-13.479283,"marketCap":692549629},{"date":"2026-03-13","current":-12.71107,"twenty":-14.294734,"median":-13.805127,"eighty":-12.961754,"marketCap":677928595},{"date":"2026-03-20","current":-11.600011,"twenty":-14.274685,"median":-13.584093,"eighty":-12.695924,"marketCap":618957093},{"date":"2026-03-27","current":-10.84065,"twenty":-14.216331,"median":-13.160447,"eighty":-12.395453,"marketCap":578505566},{"date":"2026-04-02","current":-10.748527,"twenty":-14.066263,"median":-13.052487,"eighty":-11.414439,"marketCap":574119256},{"date":"2026-04-10","current":-9.193391,"twenty":-13.930737,"median":-12.827934,"eighty":-10.709469,"marketCap":497602513},{"date":"2026-04-17","current":-10.018749,"twenty":-13.86294,"median":-12.650405,"eighty":-9.901184,"marketCap":545851924},{"date":"2026-04-24","current":-9.622204,"twenty":-13.825362,"median":-12.457995,"eighty":-9.650988,"marketCap":521483535},{"date":"2026-05-01","current":-7.206485,"twenty":-13.809991,"median":-11.744798,"eighty":-9.486381,"marketCap":528794052},{"date":"2026-05-08","current":-7.639457,"twenty":-13.779732,"median":-11.111376,"eighty":-9.258769,"marketCap":562411874},{"date":"2026-05-15","current":-7.446972,"twenty":-13.702513,"median":-10.748527,"eighty":-8.300034,"marketCap":543697644},{"date":"2026-05-22","current":-7.434647,"twenty":-13.568448,"median":-10.364346,"eighty":-8.115636,"marketCap":538772846},{"date":"2026-05-29","current":-7.796965,"twenty":-13.4527,"median":-9.998785,"eighty":-7.794875,"marketCap":568321631},{"date":"2026-06-05","current":-8.053102,"twenty":-13.287949,"median":-9.784729,"eighty":-7.758816,"marketCap":585558422},{"date":"2026-06-12","current":-6.750851,"twenty":-13.127527,"median":-9.578953,"eighty":-7.536224,"marketCap":486569993},{"date":"2026-06-18","current":-6.929006,"twenty":-13.073014,"median":-9.501773,"eighty":-7.448225,"marketCap":497404547},{"date":"2026-06-26","current":-9.2886,"twenty":-13.035188,"median":-9.467948,"eighty":-7.458553,"marketCap":661400304},{"date":"2026-07-02","current":-8.166663,"twenty":-12.965993,"median":-9.467948,"eighty":-7.479819,"marketCap":584573463},{"date":"2026-07-10","current":-8.975013,"twenty":-12.944797,"median":-9.309036,"eighty":-7.532768,"marketCap":641701114},{"date":"2026-07-17","current":-8.479177,"twenty":-12.71107,"median":-9.193391,"eighty":-7.541408,"marketCap":606735052},{"date":"2026-07-24","current":-8.981683,"twenty":-12.707304,"median":-9.020605,"eighty":-7.554336,"marketCap":638746235},{"date":"2026-07-31","current":-8.723327,"twenty":-12.661785,"median":-8.978348,"eighty":-7.610114,"marketCap":628157921},{"date":"2026-08-07","current":-9.22434,"twenty":-12.557349,"median":-9.00807,"eighty":-7.636377,"marketCap":664847662},{"date":"2026-08-14","current":-8.931525,"twenty":-12.519309,"median":-9.035172,"eighty":-7.716456,"marketCap":686763011},{"date":"2026-08-21","current":-8.496488,"twenty":-12.423423,"median":-8.981683,"eighty":-7.781927,"marketCap":661400304},{"date":"2026-08-24","current":-8.390444,"twenty":-12.400375,"median":-8.978348,"eighty":-7.793482,"marketCap":652535668}],"updateTime":1787682818119},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGMB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1186837702","title":"Agomab公布Ontunisertib治療纖維狹窄型克羅恩病的新時代2B期研究設計方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1186837702","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186837702?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 04:06","pubTimestamp":1782245174,"startTime":"0","endTime":"0","summary":"AgomAb Therapeutics公司宣布，已为其候选药物Ontunisertib针对纤维狭窄型克罗恩病的治疗，完成了名为“Nov-Era”的2B期临床研究方案设计。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184179798","title":"Agomab獲美國專利授權 肺靶向吸入式ALK5小分子抑制劑AGMB-447進入特發性肺纖維化治療研發階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1184179798","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184179798?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 19:00","pubTimestamp":1774522815,"startTime":"0","endTime":"0","summary":"生物制药企业AgomAb Therapeutics宣布，其研发的肺靶向吸入式ALK5小分子抑制剂AGMB-447已获得美国专利授权。该药物目前正针对特发性肺纤维化适应症开展临床前研究，通过精准抑制肺泡区域的TGF-β信号通路，有望为患者提供创新治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119430627","title":"Leerink Partners首次覆蓋AgomAb Therapeutics，給予「跑贏大盤」評級，目標價36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119430627","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119430627?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 19:56","pubTimestamp":1772538974,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners宣布启动对生物技术公司AgomAb Therapeutics（AGMB）的研究覆盖，并给予“跑赢大盘”评级。该机构为该公司设定了36美元的目标股价，显示出对其未来增长潜力的积极预期。\n此次覆盖标志着市场对AgomAb Therapeutics研发管线的关注升温。Leerink Partners的看好评级基于对公司核心技术与业务前景的深入评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AGMB\",params:#limit:6,delay:false,,,undefined,":[]}}